T2 Biosystems, Inc. Sustainability Profile
T2 Biosystems, Inc., a pioneering company in the field of molecular diagnostics, is headquartered in the United States. Founded in 2006, T2 Biosystems has established itself as a leader in the development of innovative diagnostic solutions, particularly in the areas of sepsis and infectious diseases. The company’s flagship products, including the T2Dx® Instrument and T2Candida® Panel, utilise advanced technology to deliver rapid and accurate results, setting them apart in the competitive diagnostics market. With a strong focus on improving patient outcomes, T2 Biosystems has achieved significant milestones, including FDA clearances and partnerships with major healthcare institutions. Their commitment to transforming the diagnostic landscape positions them as a key player in the industry, dedicated to enhancing clinical decision-making and patient care.
DitchCarbon Score
How does T2 Biosystems, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
T2 Biosystems, Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
T2 Biosystems, Inc.'s reported carbon emissions
T2 Biosystems, Inc., headquartered in the US, currently does not have any reported carbon emissions data. As such, there are no specific figures available for their Scope 1, Scope 2, or Scope 3 emissions. Additionally, the company has not outlined any reduction targets or commitments related to climate initiatives. In the absence of emissions data and reduction strategies, T2 Biosystems may be in the early stages of developing its climate commitments or may be assessing its environmental impact. The broader industry context suggests that many companies are increasingly focusing on sustainability and carbon reduction, often setting science-based targets to align with global climate goals. However, without specific commitments or data from T2 Biosystems, it is unclear how they plan to address their carbon footprint moving forward.
How Carbon Intensive is T2 Biosystems, Inc.'s Industry?
How Carbon Intensive is T2 Biosystems, Inc.'s Location?
T2 Biosystems, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
T2 Biosystems, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Thermo Fisher Scientific
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.